Preprint Review Version 1 This version is not peer-reviewed

Interplay Between Epithelial-Mesenchymal Transition and Cancer Stem Cells: Unveiling Potential Therapeutic Avenues

Version 1 : Received: 5 September 2024 / Approved: 9 September 2024 / Online: 9 September 2024 (07:14:57 CEST)

How to cite: Chatterjee, S. Interplay Between Epithelial-Mesenchymal Transition and Cancer Stem Cells: Unveiling Potential Therapeutic Avenues. Preprints 2024, 2024090627. https://doi.org/10.20944/preprints202409.0627.v1 Chatterjee, S. Interplay Between Epithelial-Mesenchymal Transition and Cancer Stem Cells: Unveiling Potential Therapeutic Avenues. Preprints 2024, 2024090627. https://doi.org/10.20944/preprints202409.0627.v1

Abstract

The global prevalence of cancer is on the rise, and while targeted therapies, early diagnosis, im-munotherapies, and conventional personalized chemotherapy have significantly upgraded out-comes for cancer patients, there is still a significant likelihood that cancer cannot be fully eradi-cated. Cancer stem-like cells (CSCs) and Epithelial-mesenchymal transition (EMT) exhibit pivotal roles in cancer cell metastasis, tumor recurrence, chemotherapy resistance, and cancer cell death, among other processes. This review aims to elucidate the molecular mechanisms underlying EMT and CSCs, their interplay, associated signaling pathways, and regulation of the EMT process and the initiation of CSCs. EMT induction confers mesenchymal properties and the potential of cancer cells to adopt the CSC state. These processes are intricately associated with the regulation of Notch and Wnt signaling pathways, transforming growth factor-β (TGF-β), as well as the expres-sion of miRNAs. Further exploring the relationship between EMT and CSCs is essential for the development of new chemotherapeutic strategies and the identification of novel therapeutic tar-gets, and hence, the development of therapeutic strategies targeting EMT, or CSCs holds promise for improving cancer therapy.

Keywords

Epithelial-mesenchymal transition (EMT); Cancer stem cells (CSCs); Hypoxia; Plasticity; Cancer signaling pathways; miRNA; Therapeutic avenues

Subject

Biology and Life Sciences, Biochemistry and Molecular Biology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.